| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.32 | 2e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 1e-07 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.28 | 2e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |